Thalidomide-NH-PEG2-C2-NH-Boc

Modify Date: 2024-04-05 23:23:46

Thalidomide-NH-PEG2-C2-NH-Boc Structure
Thalidomide-NH-PEG2-C2-NH-Boc structure
Common Name Thalidomide-NH-PEG2-C2-NH-Boc
CAS Number 2097509-40-3 Molecular Weight 504.53
Density N/A Boiling Point N/A
Molecular Formula C24H32N4O8 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Thalidomide-NH-PEG2-C2-NH-Boc


Thalidomide-NH-PEG2-C2-NH-Boc is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a PEG linker used for dBRD9 (compound 6) synthesis. dBRD9 is a selective BRD9 probe PROTAC degrader for the study of BAF complex biology[1].

 Names

Name Thalidomide-NH-PEG2-C2-NH-Boc

 Thalidomide-NH-PEG2-C2-NH-Boc Biological Activity

Description Thalidomide-NH-PEG2-C2-NH-Boc is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a PEG linker used for dBRD9 (compound 6) synthesis. dBRD9 is a selective BRD9 probe PROTAC degrader for the study of BAF complex biology[1].
Related Catalog
In Vitro dBRD9 (0-1 μM) exerts a potent anti-proliferative effect, exceeding non-degrading probe potencies in excesses of 10 to 100 fold[1].
References

[1]. David Remillard, et al. Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands.2017 May 15;56(21):5738-5743.

 Chemical & Physical Properties

Molecular Formula C24H32N4O8
Molecular Weight 504.53

 Safety Information

Hazard Codes Xi